Lutetium PSMA therapy is a treatment used in patients with advanced, castration-resistant metastatic prostate cancer. This treatment is administered by targeting a protein called PSMA found in prostate cancer cells. This protein is found in higher than normal amounts in prostate cancer cells. Lutetium PSMA treatment aims to kill cancer cells by giving a radioactive substance to prostate cancer cells by targeting this protein.